參考文獻(xiàn)/References:
[1] Ponikowski P, Voors A A, Anker S D, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J]. Eur Heart J, 2016,37(27): 2129-2200.
[2] Gazoti Debessa C R, Mesiano Maifrino L B, Rodrigues de Souza R.Age related changes of the collagen network of the human heart[J]. Mech Ageing Dev, 2001, 122(10): 1049-1058.
[3] Ahmed N.Advanced glycation endproducts--role in pathology of diabetic complications[J]. Diabetes Res Clin Pract,2005, 67(1): 3-21.
[4] 方敏, 李世玲, 王俊宏,等.晚期糖基化終產(chǎn)物對心肌成纖維細(xì)胞的老化及纖維化的影響[J]. 南京醫(yī)科大學(xué)學(xué)報:自然科學(xué)版, 2014, 34(1): 22-26.
[5] Wang Y, Luo W, Han J, et al.MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy[J]. Nat Commun,2020,11(1): 2148.
[6] Thorpe S R, Baynes J W.Maillard reaction products in tissue proteins: new products and new perspectives[J]. Amino Acids,2003,25(3-4): 275-281.
[7] Yang P, Feng J, Peng Q, et al.Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes[J]. Oxid Med Cell Longev, 2019, 2019: 9570616.
[8] Yamagishi S, Maeda S, Matsui T, et al.Role of advanced glycation end products(AGEs)and oxidative stress in vascular complications in diabetes[J]. Biochim Biophys Acta, 2012, 1820(5): 663-671.
[9] Domingueti C P, Dusse L M, Md C, et al.Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications[J]. J Diabetes Complications, 2016,30(4): 738-745.
[10] Hou X, Hu Z, Xu H, et al.Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathway[J]. Cardiovasc Diabetol, 2014,13(4): 78.
[11] 鄭煒平, 朱鵬立, 余惠珍.替米沙坦對自發(fā)性高血壓大鼠晚期糖基化終末產(chǎn)物及其受體表達(dá)水平影響及機制的研究[J]. 福建醫(yī)藥雜志, 2013,35(6): 7-9.
[12] 鄭煒平, 朱鵬立, 李峰,等.吡哆胺和替米沙坦對自發(fā)性高血壓大鼠心肌重塑相關(guān)指標(biāo)的影響[J]. 中國循環(huán)雜志,2015,30(7): 689-693.
[13] Takeuchi O, Akira S.Toll-like receptors; their physiological role and signal transduction system[J]. Int Immunopharmacol, 2001, 1(4): 625-635.
[14] Wang Y, Shan X, Chen G, et al.MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis[J]. Br J Pharmacol, 2015,172(17): 4391-4405.
[15] Lin M, Yiu W H, Wu H J, et al.Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy[J]. J Am Soc Nephrol,2012,23(1): 86-102.
[16] Liu Z W, Wang J K, Qiu C, et al.Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway[J]. Acta Phar-macol Sin,2015, 36(3): 323-333.
相似文獻(xiàn)/References:
[1]曹木根,游濠樂,陳樂昀,等.晚期糖基化終產(chǎn)物通過TLR4/MD2通路介導(dǎo)心肌細(xì)胞炎癥的機制研究[J].福建醫(yī)藥雜志,2024,46(07):64.[doi:10.20148/j.fmj.2024.07.021]
CAO Mugen,YOU Haole,CHEN Leyun,et al.Study on mechanism of AGEs mediating inflammation of cardiomyocytes through TLR4/MD2 pathway[J].FUJIAN MEDICAL JOURNAL,2024,46(01):64.[doi:10.20148/j.fmj.2024.07.021]